Saïdal’s PGD, Wassim Kouidri, claimed that the new business model adopted by the state-owned group specializing in the manufacture of pharmaceutical products will reduce the drug import bill by $1.1 billion in 2026. Read more…

4th edition of the Intra-African Trade Fair – Pharmaceutical industry: partnerships worth 400 million dollars planned
The ambition is to build a “genuine” African pharmaceutical industry, “capable of ensuring” the continent’s health sovereignty and giving it “greater weight” on the world




